Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Beneficial Ownership Report · SCHEDULE 13D/A

SenesTech, Inc.

SNESNASDAQEQUITYCurrent

Beneficial Ownership Report

Filed Oct 19, 2026Accepted Oct 19, 2026, 5:36 PM EDTFiling CIK 1680378Accession 0000902664-26-004214
Share

Structured filing — SCHEDULE 13D/A

primary_doc.xml

Open full document ↗

Amendment · This filing reports the amendment as submitted.

Subject company

Company
SenesTech, Inc.
Company CIK
0001680378
Street
13430 NORTH DYSART ROAD
Street (continued)
SUITE 105
City
SURPRISE
State / country code
AZ
Postal code
85379

Statement details

Amendment number
1
Security class
Common Stock, par value $0.0001 per share
Event date
10/15/2026
Previously filed indication
true

Authorized notification person 1

Name
Glenbrook Capital Management
Phone
650-441-9525
Street
2207, Suite B, Bellanca St.
City
Minden
State / country code
NV
Postal code
89423

Authorized notification person 2

Name
Ele Klein & Danny Goldstein
Phone
212-756-2446
Street
McDermott Will & Schulte LLP
Street (continued)
919 Third Avenue
City
New York
State / country code
NY
Postal code
10022

Reporting person 1

Name
GLENBROOK CAPITAL MANAGEMENT
Reporting person CIK
0001273782
No reporting person CIK indication
N
Citizenship / organization
NV
Reporting person type
CO
Source of funds code
AF
Legal proceedings indication
N
Aggregate amount owned
2,063,098.00
Percent of class
38.04
Sole voting power
0.00
Shared voting power
2,063,098.00
Sole dispositive power
0.00
Shared dispositive power
2,063,098.00
Aggregate excludes certain shares
N

Item 1

Issuer

SenesTech, Inc.

Security title

Common Stock, par value $0.0001 per share

Principal address

Comment

This Amendment No.1 ("Amendment No.1") amends the statement on Schedule 13D field with the SEC on July 23, 2026 (as amended from time to time, the "Schedule 13D") with respect to the Common Stock of the Issuer. This Amendment No. 1 amends Item 2(b), 3, 4, 5(a)-(c), and 7 as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 1 have the meanings set forth in the Schedule 13D.

Item 2

Principal business address

Item 2(b) is hereby amended and restated in its entirety as follows: The principal business address of each of the Covered Persons is 2207, Suite B, Bellanca St. Minden, NV 89423.

Item 3

Source of funds

Item 3 is hereby amended and restated as follows: Funds for the purchase of the securities reported herein were derived from the general working capital of the Glenbrook Funds and Accounts. A total of approximately $4.33 million (excluding brokerage commissions) was paid to acquire such securities. Positions in the shares of Common Stock may be held in margin accounts. Because other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase the shares of Common Stock.

Item 4

Purpose of transaction

Item 4 is hereby amended and supplemented as follows: From time to time, the Reporting Person may engage with members of the board of directors of the Issuer (the "Board") and management, and may engage with other stockholders and other relevant parties, regarding, without limitation, its concerns regarding the composition of the Board, including whether the Board, as currently constituted, has the appropriate mix of skills, experience and perspectives to oversee the Issuer's strategy and execution, and issues regarding the size, composition and refreshment of the Board, the identification of potential director candidates, Board leadership and committee composition, and the Issuer's corporate governance practices. Depending on the outcome of such discussions and other factors the Reporting Person deems relevant, the Reporting Person may take such actions with respect to the composition of the Board as it deems appropriate, which may include recommending changes to the Board, seeking to fill any vacancy on the Board, or proposing or nominating one or more director candidates for election at a meeting of the Issuer's stockholders. The Reporting Person has not made any determination as to any specific course of action, and there can be no assurance that the Reporting Person will take any such action. On October 19, 2026, GCM issued a press release and public letter regarding the Issuer, which is attached as Exhibit 99.1 hereto and incorporated by reference herein.

Item 5

Number of shares

Item 5(b) is hereby amended and restated as follows: See rows (7) through (10) of the cover page to this Schedule 13D for the number of shares of Common Stock as to which the Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

Transactions

Item 5(c) is hereby amended and restated as follows: All transactions in the shares of Common Stock effected by the Reporting Person during the past sixty (60) days, which were all in the open market, are set forth in Schedule A hereto, and are incorporated herein by reference.

Percentage of class

Item 5(a) is hereby amended and restated as follows: See rows (11) and (13) of the cover page to this Schedule 13D for the aggregate number of shares of Common Stock and percentages of shares of Common Stock beneficially owned by the Reporting Person. The aggregate percentage of shares of Common Stock reported to be beneficially owned by the Reporting Person is based upon 5,423,542 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, filed with the SEC on August 6, 2026.

Item 7

Filed exhibits

Item 7 is hereby amended and supplemented by adding the following: Exhibit 99.1 Press Release and Public Letter, dated October 19, 2026.

Signature 1

Reporting person
GLENBROOK CAPITAL MANAGEMENT
Signed
/s/ Robert W. Lishman
Title
Robert W. Lishman, Director
Date
10/19/2026

Filed exhibits

Company context

SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The company’s groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech’s mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.

Current securities

Historical securities (1)

Recent company filings

  1. 4 filingOct 30, 2026
  2. SCHEDULE 13D/A - filed by GLENBROOK CAPITAL MANAGEMENT regarding SenesTech, Inc.Oct 30, 2026
  3. 4 filingOct 22, 2026
  4. SCHEDULE 13D/A - filed by GLENBROOK CAPITAL MANAGEMENT regarding SenesTech, Inc.Oct 22, 2026
  5. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureOct 22, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.